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to compare flnal thrombus scores and CTFC results between unprotected vs. Angiojet 
vs. Percusurge groups. Results: The mean initial CTFC in the unprotected stenting vs. 
Angiojet vs. Percusurge groups was 83.8, 72.5, and 90.8 respectively. Although the 
mean final Angiojet CTFC was lower than the unprotected group (25.8 +/- 13.4 vs. 27.6 
+/- 19.3). the difference was not statistically significant (p=O.55). However, comparison 
between the final CTFC in the Percusurge group and the unprotected group was statisti- 
cally significant (17.f +/- 6.2 vs. 27.6 +i- 19.3, pzO.02). The Angiojet group had less 
thrombus than the unprotected group (3.9 +/- 1.0 vs. 4.4 +/- 0.86, p<O.O02). There was 
no significant difference in thrombus scores in the Percusurge and unprotected groups 
(4.6 +/- 0.78 vs. 4.4 +I- 0.86, ~~0.3). Conclusions: The use of distal protection during 
AMI percutaneous intervention improves the fInal CTFC. This correlates with decreased 
in-hospital and long term mortality. We, therefore, recommend the use of distal protection 
in more thrombus burdened AMI stenting. 
1097-95 Benefits and Risks of Abciximab Use in Primary 
Angioplasty for Acute Myocardial Infarction: The 
CADILLAC Trial 
David E. Kandzarl, James E. Tcheng, Cindy L. Grines, Mark Effron, David A. Cox, 
Eulogio Garcia, John J. Griffin, Giulio Guagliuml, Thomas D. Stuckey, Mark Turco. 
Alexandra J. Lansky, Roxana Mehran, Gregg W. Stone, Duke Clinical Research Institute, 
Durham, NC, Cardiovascular Research Foundation. New York, NY 
Background Modest-sized trials examining the benefit of glycoprotein IlbAlla Inhibition 
as adjunctive therapy in primary percutaneous coronary intervention (PCI) have demon- 
strated improved early cllnical and angiographic outcomes. yet variability in trial design, 
sample size. and late outcomes have precluded these studies from being definitive. 
Methods We performed a two-way comparison of early and late outcomes for 2,082 
AMI patients undergoing primary PCI (PTCA or stenting) who were randomized to abcix- 
imab (abcx. 1x1052) or control (n=1030). 
Results Despite similar baseline cllnical and angiographic characteristics, abcx treat- 
ment was associated with a signlflcant reduction in the 30-day occurrence of death (D), 
repeat myocardial Infarction (reMI), ischemia-driven target vessel revascularization 
(TVR), or disabling stroke (7.0% vs. 4.8% OR 1.54, 95% Cl, 1.08 to 2.19, p=O.Ol). In 
patients randomized to abcx, TIMI 3 flow tended to be greater at baseline prior to abcx 
(20.3% vs. 23.8%, p=O.O6), and was more frequently present post-procedure (94.8% ver- 
sus 96.5%, p=O.O3). Severe bleeding was not increased with abcx. 30.day subacute 
thrombosis rates were also reduced by abcx (1.5% vs. 0.4%. p=O.Ol). By 12 months. 
abcx was no longer associated with significant differences in the composite endpoint 
(18.4% for controls vs. 16.9% for abcx. p=O.29). Myocardial salvage, angiographic rest- 
enosis, and infarct artery reocclusion at 7.month follow-up angiography were unaffected 
by abcx treatment. Although the absolute difference in ischemic TVR rates between the 
two groups persisted at 1 year, the relative difference was no longer statistically slgnifi- 
cant, in part due the lack of influence by abcx on restenosis and accrual of repeat revas- 
cularlzation procedures. No significant Interaction between coronary stenting and abcx 
was observed. 
Conclusions Abciximab treatment, when administered just prior to intervention as 
adjunctive therapy to primary PCI, is associated with significant reductions in early 
adverse outcomes. In spite of an overall early reduction in the composite endpoint, abcx 
treatment does not significantly influence the occurrence of D. reMI, or restenosis at 1 
year. 
1097-96 Differences in Outcome of Primary Angioplasty for 
Acute Myocardial Infarction During Routine Duty Hours 
Versus During Off-Hours: Is It the Patient or Is It Care? 
Jose P. Henriaues, Amout P. Haasdijk, Felix Zijlstra. lsala Klinleken, Locatie 
Weezenlanden. Zwolle, The Netherlands 
Background: A circadvan variation in the time of onset of acute myocardral infarction with 
a peak I” the morning hours has been described. We sought to investigate the impact of 
circadian patterns on the practice of primary angioplasty. 
Methods and results: We studied 1702 consecutive patients with acute ST segment ele- 
vation myocardial Infarction treated with primary angioplasty. We observed circadian 
variation in frequency of symptom-onset, hospital admission, and first balloon inflation. 
Circadian patterns of symptom-onset, hospital admission and balloon inflation are simi- 
lar. A majority of patients have symptom-onset (53%), hospital admission (53%) and first 
balloon inflation (52%) during daytime working hours (OS.OO-18.OOh). There were no dif- 
ferences in baseline clinical characteristics or treatment delays between routine duty 
hours and off-hours patients. Hospital admlssion between 08.00 and 18.00 was associ- 
ated with an angioplasty failure rate of 3.8%, compared to 6.9% between 18.00 and 
08.00. pcO.01. Thirty day mortality was 1.9% in patients wth hospital admission between 
08.00 and 18.00, compared to 4.2% in patients with hospital admission between 18.00 
and 08.00, p<O_Ol. 
Conclusions: Cwzadian variations may have a profound effect on the practice of pnmary 
angioplasty. A majority of patients is treated during the daytime. Patients treated during 
off-hours have a more often failed angioplasty and consequently worse clinical outcome, 
when compared to patients treated during routine duty hours. 
1097-97 lntracoronary Thrombectomy Improves Myocardial 
Reperfusion in Patients Undergoing Direct Angioplasty: 
A Single-Center Randomized Study 
Massimo Napodano, Bernhard Reimers, Giampaolo Pasquetto, Salvatore SaccB, Cario 
Cemetti. lvano Dell’Olivo, Pletro Pascotto, Mirano Hospital, Mirano. Italy 
Background. Embolizatlon of thrombus and plaque debris during angioplasty for acute 
myocardlal Infarction (AMI) may lead to obstructions in the microvascular system, caus- 
ing suboptimal twue repedusion. Mechanical intracoronaly thrombectomy is thought to 
reduce macro and micro embolization of debris, potentially improving myocardial tepedu- 
sion. We thought to elucidate the effects on myocardial repelfusion of mechanical throm- 
bectomy as adjunct to coronary stentlng in the setting of direct angloplasty for AMI. 
Methods: 92 patients with acute myocardial infarction and angiographic evidence of 
intraluminal thrombus were randomized to coronary thrombectomy followed by stenting 
(46 patients) or to stenting alone (46 patients). Thrombectomy was performed using the 
X-Sizer catheter (EndiCOR Inc. San Clemente. CA, USA). TIMI flow grade, diameter 
stenosis, minimal lumen diameter (MLD) were assessed at baseline and after the proce- 
dure. Myocardial repeffusion was assessed according to angiographic (Myocardial Blush 
Grade) and ECG criteria (ST segment resolution). 
Results: Baseline clinical and angiographic characteristics were similar between groups. 
Postprocedural TIMI flow, MLD and diameter stenosis were not different between groups 
(p=ns). The blush 3 was observed more often in patients underwent thrombectomy than 
in patlent who did not: 33 of 46 (71.7%) patients versus 17 of 46 (36.9%) (p=O.O06). 
Assessing the reperfusion according to ECG criteria, post-procedural ST-segment eleva- 
tion appeared normalized compared to baseline in 27 of 46 patients (58.7%) of throm- 
bectomv aroup versus 15 of 46 (32.6%) of arow aswaned to conventional strateav. 
regressed> 56% in 11 (23.9%) versus 9 il9.8;). and remained unchanged in 8 (17.4%) 
versus 22 oatients (47.8%) resoectivelv fo=O.OOl).There was a trend toward more no- , 
reflow and distal embolizations in patients not underwent thrombectomy (p=O.O9 and 
p=O.O6 respectively). By multivarlate analysis the use of X-Sizer was an independent 
predictor of Blush-3 (p= 0.001). 
Conclusions: lntracoronary thrombectomy during direct angioplasty improves myocar- 
dial repeiiwon as assessed by myocardial blush grade and ST-segment resolution. 
1097-98 Impact of Multivessel Coronary Artery Disease on In- 
Hospital Outcome in Patients Treated by Immediate 
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Background. The aim of the study was to analyze in-hospital outcome of patients (pts) 
with acute myocardial infarction (AMI) treated by immediate angioplasty (PCI) with and 
wlthout other significant stenoses in non-infarct related artery. 
Methods A total of 970 consecutive pts with AMI (77% male, mean age 57.0*11.2 
years) treated by immediate PCI were compared, according to coronary angiography, in 
the two groups: the SINGLE group (456 pts without other stenoses >50%) and the 
MULTI group (514 pts with multivessel disease). Thrombolytlc treatment was adminis- 
tered before PCI to 378 (39%) of pts. 
Results In MULTI group pts were older (59.5klO.9 vs. 54.2ill.O years in SINGLE 
group, p<O.OOOl) and the time from the onset of AMI to admission was longer (4.2t2.9 
vs. 5.le4.6, p=O.OOl). Dtabetes (24.4% vs. 15.6% p<O.OOOl), history of hypetienslon 
(56.8% vs. 43.2%. pcO.0001) and prior Ml (29.4% vs. lO.i%, p<O.OOOl) were more fre- 
quent, whereas smoking (60.2% vs. 68.4%. p=O.O078) and anterior locatlon (35.6% vs. 
50.0% p<O.OOOl) were less common in the MULTI group. Cardiogenic shock (CS) on 
admission was present in 15% of pts in MULTI compared to 7% III SINGLE group. 
p<O.OOOl. Procedural and in-hospital outcome is presented !n the table. 
N (%) 
Baseline TIMI 2 or 3 flow 
Final TIMI 3 flow 
Stent implantation 
Ejection fraction 
Reocclus~on 
Bypass surgery 
In-hospital mortality 
Pts without CS on admission 
Pts with CS on admlssion 
MULTI 
514 (53%) 
33.1 % 
89.1 % 
51.4 % 
43.3t8.4 
7.0 % 
8.4 % 
8.0 % 
111437 (2.5%) 
30/77 (39%) 
SINGLE 
456 (47%) 
P value 
38.2 % 0.099 
91.5 % 0.22 
59.2 % 0.014 
45.7+7.8 <O.OOOl 
4.8 % 0.15 
0.4 % <0.0001 
2.6 % 0.0003 
4/424 (0.9%) 0.078 
8/32 (25%) 0.16 
Conclusion Despite similar effectiveness of PCI, patients with AMI and multwessel dis- 
ease have worse in-hospital outcome. One of the reasons for that is higher incidence of 
cardiogenic shock on admission. 
